Syngenta Sues BASF for Infringing U.S. Herbicide Patent

Agricultural company Syngenta has sued German chemical giant BASF (BASFn.DE), opens new tab, alleging in a Delaware lawsuit that BASF’s new corn herbicide Ridivex infringes a patent related to Syngenta’s competing herbicide Storen, according to Reuters.
Syngenta said in the complaint, opens new tab, filed Tuesday and made public on Wednesday, that Ridivex misuses its patented chemical formula for a weed killer combined with a crop “safener” to protect crops from damage.
Syngenta said that Ridivex is expected to be approved by the U.S. Environmental Protection Agency “within days,” which would clear the way for BASF to begin selling it, and asked the court to block BASF from launching its herbicide in the United States.
Syngenta told the court that BASF could siphon away important sales of its Storen herbicide if allowed to begin selling Ridivex before the autumn planting season.
“The June–September distributor purchasing window is a critical inflection point that largely determines sales outcomes for the entire year,” Syngenta said in the lawsuit. “If a competing product enters the market during or before this distributor purchasing window — particularly one positioned as a direct alternative to Storen — it can displace Syngenta’s product before sales to growers even begin.”

Facts Only

* Syngenta sued BASF in a Delaware lawsuit.
* The suit alleges BASF’s corn herbicide Ridivex infringes a patent related to Syngenta’s Storen herbicide.
* Syngenta claims Ridivex misuses its patented formula for a weed killer combined with a crop “safener.”
* Syngenta asked the court to block BASF from launching Ridivex in the United States.
* Syngenta warned that early market entry could displace sales of Storen herbicide.
* The June–September distributor purchasing window is described as a critical inflection point for sales outcomes.

Executive Summary

Agricultural company Syngenta has filed a Delaware lawsuit against German chemical giant BASF alleging patent infringement related to herbicides. The complaint claims that BASF’s new corn herbicide, Ridivex, misuses a patented chemical formula for a weed killer combined with a crop “safener.” Syngenta requested the court to block the launch of Ridivex in the United States, arguing that it could displace sales of Syngenta’s Storen herbicide during the critical June–September distributor purchasing window. Syngenta contends that if Ridivex enters the market before this period, it could siphon sales from Storen before growers begin planting. The lawsuit seeks to prevent BASF from launching the product in the U.S. pending resolution of the patent dispute.

Full Take

The core tension in this dispute lies at the intersection of intellectual property rights and market timing within the agricultural supply chain. The argument shifts from a pure legal claim of infringement to an analysis of competitive strategy, specifically focusing on temporal market advantage. Syngenta is not merely asserting a right over a patent; it is attempting to control access to a specific window of commercial opportunity that dictates annual sales figures for both products. This dynamic suggests that the value of the patent extends beyond the molecule itself and into the sequence of market entry relative to established distribution cycles. The implication is that patent litigation in complex industries often becomes a proxy battle over market sequencing rather than just ownership definitions. Further inquiry should focus on how regulatory approval timelines interact with these distributor purchasing windows, and what precedent exists for judicial remedies designed to protect temporal sales opportunities against broad product launches.